SBP

Simple Point-Of-Care Nucleic Acid-Based Hepatitis C Virus Ribonucleic Acid Test

产品代码
SBP
器械名称
Simple Point-Of-Care Nucleic Acid-Based Hepatitis C Virus Ribonucleic Acid Test
管理类别
第 2 类(Class II)
21 CFR 条款
21 CFR 866.3171
FDA 专业组
Microbiology
上市路径
需提交 510(k) 上市前通告
该代码近三年的 510(k)
1 件
其中 Summary 已存档
0 份,可直接下载
FDA 历史累计 510(k)
1 件(全部年份;本站只收录近三年的明细)

FDA 分类定义

A simple point-of-care nucleic acid-based hepatitis C virus (HCV) ribonucleic acid (RNA) test is an in vitro diagnostic device that is intended for prescription use for the detection of HCV RNA in clinical specimens as an aid in the diagnosis of HCV infection or as an aid in the management of HCV-infected patients, including individuals without antibodies to HCV. This device is simple to use and does not involve sample manipulation, transportation of the sample to another functional area (e.g., a central laboratory or other specialized area), or measurement of reagents or analytes that could be affected by conditions such as sample turbidity or cell lysis. The test is not intended for use as a donor screening test for the presence of HCV RNA in blood, blood products, or tissue donors.

定义原文来自 FDA 器械分类库,属美国联邦政府作品(公有领域)。

该代码近三年的 510(k)(1 件)

数据窗口为最近三年。最新一件:2024-06-27。

510(k) 号批准日期申请人器械名称摘要
DEN2400162024-06-27CepheidXpert HCV; GeneXpert Xpress System
FDA 官方分类页: SBP
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。